GenturaDx   www.progentech.com
凯晟生物科技有限公司成立于2005年5月，坐落在美国高科技研发中心——硅谷。是由数位在分子生物学、生物化学、微电子学、市场营销学方面的专家创建而成，专业致力于核酸蛋白纯化等分子诊断领域。公司于2008年3月成功融资2100万美元。

公司的第一个产品Entura 全自动核酸蛋白纯化系统于2008年通过UL、CE验证。目前，已经通过直销或者经销的方式全面销售。

在硅谷、上海各团队的领导下，凯晟生物科技有限公司将为生命科学、分子诊断领域提供最优质的产品和服务。

ProGenTech 是一家位于上海、苏州和加州 Emeryville 的生命科学与诊断公司。该公司成立于2005年，如今拥有员工80名。该公司首个产品 Entura 于2007年11月在亚洲推出。

ProGenTech 改名为GenturaDx
2012年Luminex收购分子诊断公司GenturaDx

  

ProGenTech Limited is a life science and molecular diagnostics company committed to developing next generation instrumentation for nucleic acid and protein purification and molecular diagnostic testing. The company was founded in 2005 and has offices in the San Francisco Bay Area and Shanghai.

The company’s proprietary Entura Lite instrument is a simple and efficient sample preparation platform designed to increase efficiency in the lab through true walk away automation. The Entura Lite is compatible with the company’s unique disposable cassettes, which carry all the reagents onboard that are required to isolate a variety of nucleic acids and proteins from a variety of sample types.

The Entura Lite platform and disposable cassette serves as the foundation for ProGenTech’s fully-integrated instrument for molecular diagnostic testing that is currently under development. The initial diagnostic assays for use on the integrated system will be specific to detecting hospital-acquired infection targets.